Precision Healthcare: Patient Care, Decision Tools, Wearables, Legal and Ethical Issues

Precision Medicine (PM) is an expanding discipline that necessitates the use of novel technologies to provide uniformity in data gathering from more than 1 million individuals and manage vast quantities of patient data. Nevertheless, ethical, social, and legal considerations, such as privacy, informed consent, and cost, present substantial obstacles. The idea requires significant government funding, amounting to millions of dollars, and must get approval from Congress over many years. Physicians and healthcare professionals must thoroughly comprehend molecular genetics and biochemistry to incorporate this technology into conventional healthcare procedures effectively. A precision health system necessitates a strategy that encompasses healthcare providers, payers, pharmaceutical firms, Information Technology (IT) businesses, employers, governments, and social groups in an interconnected manner. The system employs sensing technologies, computations, and communication to guarantee health data's security, privacy, and reliability. This chapter examines the goals, difficulties, implementations, and remedies of precision healthcare using Artificial Intelligence (AI) and Machine Learning (ML) methodologies.

Precision healthcare is an approach aimed at delivering personalized medical treatments tailored to the unique needs of individuals. Personalized medicine, also known as precision medicine, is a healthcare approach that considers genetics, lifestyle, and environmental factors, classifying individuals based on their medical histories. Its goal is to prevent disease and develop target-based solutions for various medical conditions. Serving as a predictive model, this model aids in developing medical solutions customized explicitly to the ailment at concern. The practical implementation of this model requires collecting and analyzing large datasets. This presents a global challenge for the effective implementation of precision medicine. It also raises ethical, social, and legal concerns, including the importance of safeguarding patients' private health information. Millions of dollars in funding are required for precision medicine to be implemented successfully over the long term. Another significant issue that must be addressed when addressing the concept of precision medicine is the necessity for trained professionals. Large datasets can be handled due to contemporary technologies like machine learning and artificial intelligence. Additionally, researchers working together to improve the results are advantageous. Shortly, patients and healthcare professionals can look forward to the greatest tailored therapies and treatments with the advancements in modern medicine. This chapter addresses the challenges faced in effectively implementing precision medicine healthcare and discusses solutions for efficient healthcare delivery to improve patient outcomes for disease prevention.

The Internet of Medical Things (IoMT) revolutionizes healthcare by establishing connections between medical equipment and systems to provide more intelligent and streamlined care. This study examines the transformative influence of the Internet of Medical Things (IoMT) on healthcare, with a specific emphasis on its capacity to improve patient outcomes using remote monitoring, tailored treatment, and the management of chronic diseases. Additionally, it analyses how the Internet of Medical Things (IoMT) improves the effectiveness of healthcare operations, resulting in cost reduction and streamlined workflows. With the increasing adoption of the Internet of Medical Things (IoMT), it is crucial to prioritize strong security and data privacy. This involves implementing effective cybersecurity measures and adhering to regulatory compliance to safeguard patient data. Despite the presence of hurdles such as interoperability and infrastructure needs, the future of the Internet of Medical Things (IoMT) holds the potential for a healthcare system that is more interconnected and efficient. Healthcare providers can achieve better patient care, optimize resource allocation, and contribute to a healthier future by adopting the Internet of Medical Things (IoMT).

Lung diseases cover a wide range of conditions that affect how we breathe and create serious public health issues. This chapter gives an organized overview of pulmonary disorders, sorting them by anatomical areas and disease features. A thorough review of recent literature shows new progress in finding and classifying lung diseases, mainly focusing on computer-based methods. The chapter also examines the role of deep learning, a component of artificial intelligence, in addressing complex diagnostic tasks that have traditionally relied on human expertise. By utilizing neural networks and data-driven methods, deep learning enables the accurate identification of lung infections and enhances predictions in clinical settings. The chapter discusses new technologies like machine learning, the Internet of Things (IoT), and intelligent sensing systems for their potential to change respiratory healthcare. The aim is to update researchers and practitioners on the convergence of biomedical science and innovative computing.

The increasing global population, climate change, aging and chronic diseases, availability of healthcare facilities in selected cities and towns, and increasing cost of medical expenses are just a few reasons that are driving transitions from traditional hospital-based systems to individual-centric healthcare systems. With advancements in the semiconductor industry, material science, and data science, wearable technology has seen noticeable advancement and growth. The chapter aims to cover the technical aspects involved in wearable technology. The work delved deep into the architecture aspects, energy harvesting and management, and data processing cycle, forming the technological backbone for monitoring and transferring vital body signals to remote locations. The aggregate information helps detect, prevent, and monitor diseases in healthcare. The chapter thoroughly discusses the wearable type in healthcare and the latest devices commercially available for consumption in the healthcare industry. The chapter highlights the limitations and challenges hindering their availability at the grassroots population level. This chapter aims to ensure that technological advancements can be comfortable and healthy for ordinary people.

This chapter uses two datasets to predict heart attacks, which provide valuable insights into the machine learning algorithms used in the prediction process. The first dataset used in this chapter is the heart attack risk prediction dataset, which has 14 attributes relevant to heart health, including demographic information of the patient, clinical features, diagnostic test results, symptoms, risk factors, and outcome variables. The second dataset used in this chapter is the heart attack dataset collected at Zheen Hospital in Erbil, Iraq, in 2019. The dataset has 1319 records of patients and nine attributes indicating the heart health status of the patients. The categorical data is normalized and represented in the dataset. This chapter aims to predict the risk of a heart attack using three machine learning algorithms. Since both datasets used in this chapter have labeled data, these algorithms should fall under the category of supervised machine learning, where the machine learns from the data provided in the training process to predict the results for the test data. Decision Tree, Random Forest, and K Nearest Neighbors (KNN) are the methods selected for this chapter based on several criteria. Incorporating several datasets permits the identification of issues related to data heterogeneity and sample size limitations and, thereby, the examination of the model's generalizability and reliability.

Cardiovascular illnesses are a significant contributor to illness and death on a global scale, highlighting the importance of identifying them early and implementing preventative healthcare measures. The highest heart rate reached during physical activity, referred to as 'heartRate', is a crucial measure of an individual's cardiovascular well-being. Precisely forecasting this parameter can aid in promptly identifying individuals in danger, enabling immediate medical intervention. This study uses machine learning techniques to forecast 'heartRate' by examining various physiological and clinical characteristics. The chapter describes the utilization of Linear Regression, Random Forest, and Gradient Boosting models, with each model evaluated for its prediction accuracy. This work examines the inherent obstacles in machine learning applications in healthcare, including data imbalance and model interpretability. It offers a thorough review of the effectiveness of models used for predicting cardiovascular health indicators. This undertaking is not solely focused on forecasting a numerical value but on comprehending the complex connections among many health variables and how they collectively impact cardiovascular function. The goal is to aid in the early diagnosis of health issues and provide individualized healthcare solutions.

Machine learning is central in analyzing numerical diabetes datasets to predict disease progression and patient outcomes. The primary objective is to develop a model that accurately forecasts the patient's future health status based on historical and current medical data. Predictive analytics is essential for early intervention and personalized patient care. The chapter focuses on the pressing healthcare challenge of diabetes, a pervasive condition characterized by significant complexity and requiring precise diagnostic measures. Recognizing the ample data available on diabetes and the severe complications associated with the disease, there is an imperative demand for enhancing the accuracy of its diagnosis. The dataset utilized in this chapter was meticulously compiled from patient records within the Iraqi healthcare system, specifically sourced from the Medical City Hospital's laboratory and the Specialized Center for Endocrinology and Diabetes at Al-Kindy Teaching Hospital. To advance the diagnosis and predictive modeling of diabetes, a comprehensive dataset was curated, drawing from a wide range of medical and laboratory analysis records. This dataset was pivotal in fostering a deeper understanding of the multifactorial nature of diabetes within Iraqi society. Support Vector Regression (SVR), Random Forest Regressor, and K-Nearest Neighbors Regressor (KNN) were applied to the tested dataset. In the experimental results, the SVR model showed the most significant improvement postoptimization, with substantial decreases in Mean Squared Error (MSE), Root Mean Squared Error (RMSE), and Mean Absolute Error (MAE), and a notable increase in R2, indicating a substantial enhancement in both the model's accuracy and its explanatory power.

Healthcare will significantly shift, and LLMs will play a significant role in this industry. Retraining the use of medical databases or generic LLMs to finetune might help develop strategies to improve the usability of LLMs for healthcare. Additionally, multimodal LLMs feature fusion using various data sources, including tabular and visual data, which leads to even greater performance than humans. Even though there are many advantages to using LLMs, it is essential to acknowledge that the content created cannot be solely the responsibility of LLMs. To prevent any potential harm, it is crucial to thoroughly evaluate anything AI generates. Reducing the bar for LLM deployments means that there is more time to focus on improving deployment requirements. To better assist clinical decision-making, efforts should encourage incorporating LLMs in medicine, strengthen human-machine collaboration, and enhance LLM interpretability in clinical contexts. Physicians may optimize the advantages of AI while minimizing possible hazards and improving patient outcomes by utilizing LLMs as an auxiliary tool. Ultimately, the cooperation of administrators, patients, data scientists, doctors, and regulatory agencies will be necessary to integrate LLMs into healthcare effectively.

The adoption of new technology by a nation plays a vital role in its growth. The use of AI systems in the healthcare sector holds a stronger position with the increasing presence of advanced technology. These systems provide recognition to the processing and analysis stage, where medical data is considered, its pattern is located, and information is gathered. However, there is a high risk involved when any new form of technology is utilized in reality. In society, there is a need to understand the significance of maintaining both ethical and legal aspects when using AI systems. With transformative technology, the livelihood of an individual is impacted. In healthcare, any error in procedures and protocols can lead to disaster. The integration of these systems in medical practice requires an effective legal framework that can safeguard human health. There is a need for training and education sessions for the stakeholders to have awareness of the new technologies’ complexities. This chapter will highlight the critical concerns that are required to be taken into focus to maintain privacy and algorithmic transparency. It guides the policy draft makers to consider the moral grounds to ensure accessibility. Since the level of danger is unpredictable, the AI utilization needs to have its limitations. With effective harmonized governance, the adoption of AI will navigate more opportunities and build a landscape that will be beneficial for mankind.

Artificial Intelligence (AI) is rapidly transforming the healthcare landscape, offering exciting possibilities from drug discovery to improved disease diagnosis and treatment planning. Real-world examples are woven throughout the paper to illustrate the significant impact AI already has on various aspects of patient care. However, implementing AI in healthcare is not without its challenges. Ethical considerations, data privacy concerns, and potential biases in algorithms are all critical issues that demand careful attention. The paper emphasizes the importance of transparency, fairness, and trust in developing and deploying AI-powered healthcare solutions. Obtaining informed consent from patients when AI is involved in their diagnosis or treatment is a complex issue that needs to be addressed. Ensuring the reliability and safety of AI algorithms, while maintaining transparency in the development process, presents another hurdle. Mitigating bias in AI algorithms is crucial to guarantee fair and equitable treatment for all patients. Finally, protecting patient privacy while enabling data sharing for AI development presents a significant challenge. Collaboration among healthcare professionals, AI developers, and policymakers is crucial to ensure that AI is used responsibly and effectively to improve healthcare outcomes for all. Beyond the potential of AI, the paper delves into the legal and ethical considerations that arise with its use in medicine.
The first aspect to consider is the copyright and patent rights associated with AI creations, as well as the question of liability. Can AI be held liable for medical negligence? If so, who is responsible – the AI itself, its creator, or some combination? These questions become even more relevant in the context of established medical negligence jurisprudence. This paper seeks to understand how different countries are approaching AI-based medical treatments and explores the prospects for future development. It also discusses the legal and ethical implications that may arise, analyzing the advantages and disadvantages of investing in AI for healthcare. By undertaking a doctrinal research approach, the paper critically evaluates the prospects of integrating AI into the healthcare sector and analyzes the policy and legal frameworks needed to ensure responsible use. This research is particularly relevant for policymakers and legal professionals responsible for shaping AI's future in healthcare.

Précision healthcare is a revolutionary approach to medicine that emphasizes individualized treatment plans based on each patient's unique needs. This abstract delves into several aspects of précision healthcare, including wearable technology, sophisticated decision-making tools, patient care paradigms, and related ethical and legal issues. Précision healthcare transforms patient care through clinical, genetic, and lifestyle data by tailoring treatment plans to optimize benefits and reduce adverse effects. Modern systems must process complex decision-making information, like Artificial Intelligence (AI) and Machine Learning (ML) algorithms, to accurately and promptly inform healthcare decisions. With the ability to continuously monitor vital signs, exercise levels, and illness biomarkers, wearables have become essential components of précision healthcare. These gadgets make it possible to gather real-time data, improving early health anomaly detection and remote patient monitoring. Nonetheless, there are important moral and legal issues with applying précision medicine. Considering problems like patient consent for data use, privacy protection, and fair access to cutting-edge technologies is essential. Regulatory frameworks must change to promote innovation in healthcare delivery and guarantee adherence to ethical norms and data protection regulations. In navigating the complex legal and ethical considerations terrain, this chapter offers a thorough overview of the multifaceted landscape of précision healthcare, highlighting its potential to revolutionize patient outcomes through tailored treatments, cutting-edge decision tools, and wearable technologies.